Amgen Inc. sell Bank of America Co.
Start price
23.07.25
/
50%
€261.75
Target price
23.07.26
€222.32
Performance (%)
19.08%
Price
31.03.26
€304.40
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 19.08%. Dividends of €7.28 are taken into consideration when calculating the performance. This prediction currently runs until 23.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.512% | 0.512% |
| iShares Core DAX® | -1,66 % | -10,87 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % |
| iShares S&P 500 | -2,30 % | -4,80 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Corporation from $252.00 to $261.00. They now have an "underperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat